Translocation 2; 19 in a patient with probable relapsed acute myeloid leukemia

Pathobiology

Volumn 65, Issue 4, 1997, Pages 223-228

  Mark, Hon Fong Louie ^a,b,d   Gray, Yulia ^b   Rintels, Peter ^c,d  

^a Lab Cytogenet FISH/Genotoxicology   (United States)

^b Departments of Pathology and Clinical Hematology   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

Acute myeloid leukemia; Translocation

Indexed keywords

PLASTIC; POLYMER;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ARTICLE; BUILDING INDUSTRY; CASE REPORT; CHROMOSOME TRANSLOCATION 19; CHROMOSOME TRANSLOCATION 2; DATA BASE; GENOTOXICITY; HUMAN; HUMAN CELL; KARYOTYPE; MALE; MEDICAL LITERATURE; OCCUPATIONAL HEALTH; OIL INDUSTRY; PRE B LYMPHOCYTE; PRIORITY JOURNAL; RELAPSE;

ADULT; CHROMOSOMES, HUMAN, PAIR 19; CHROMOSOMES, HUMAN, PAIR 2; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; RECURRENCE; TRANSLOCATION, GENETIC;

EID: 0030830446     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000164127     Document Type: Article

References (38)

1. Bennett JM, Catovsky D, Daniel MT. Flandrin G. Galton DA. Gralnick HR. Sultan C: Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985;103:620-625.
2. Nisson PE. Watkins PC. Sacchi N: Transcriptionally active chimeric gene derived from the fusion of the AML I gene and a novel gene on chromosome 8 in the t(8:2l) leukemic cells. Cancer Genet Cytogenet 1992;63:81-88.
3. Liu P. Tarle SA, Hajra A. Claxton DF. Marlton P, Freedman M. Siciliano MJ, Collins FS: Fusion between transcription factor C'BFp/ PEPBP2b and a myosin heavy chain in acute myeloid leukemia. Science 1993:261:1041-1044.
4. deThe H. Lavau C. Marchio A. Chonienne C. Degos L. Dejean A: The PML-RARa fusion mRNA generated by the t(15; 17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 1991;66:675-684.
5. Mark HFL, Dong H, Glasser L: A multimodal approach for diagnosing patients with acute promyelocytic leukemia (APL). Cytobios 1997; 87:137-149.
6. Fenaux P, Le Delcy MC. Castaigne S, Archim-beaud E. Chomienne C, Lin KH, Guerci A. Duarte M. Daniel MT. Bowen D: Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multi-center randomized trial. European APL 91 Group. Blood 1993:82:3241-3249.
7. Bloomfield CD, Lawrence D. Arthur DC: Curative impact of intensification with high-dose Ara-C in acute myeloid leukemia varies by cytogenetic group (abstract 431). Blood 1994: 84:(suppl 1)111.
8. Moorhead P. Nowell P. Mcllman W: Chromosome preparation of leukocyte cultures from human peripheral blood. Exp Cell Res 1960; 20:613-616.
9. Sumner AT, Evan AJ, Buckland RA: New technique for distinguishing between human chromosomes. Nature 1971;232:31-32.
10. Braun L. Mikumo R. Mark HFL. Lauchlan S: Analysis of the growth properties and physical state of the human papillomavirus type 16 genome in the cell lines derived from primary cervical tumors. Am J Pathol 1993; 143:832-844.
11. Mark HFL: Bone marrow cytogenetics and hematologic malignancies; in BJ Kaplan. KS Dale (eds): The Cytogenetic Symposia. Burbank. The Association of Cytogenetic Technologists. 1994.
12. Mark HFL, Ahearn J, Lathrop J: Constitutional trisomy 8 mosaicism and gestational trophoblastic disease. Cancer Genet Cytogenet 1995: 80:150-154.
13. Mark HFL. Hann E. Mikumo R. Lauchlan S, Beauregard L, Braun L: Cytogenetic characterization of three cell lines derived from primary cervical tumors. Ann Clin Lab Sci 1995:25: 185-199.
14. Mark HFL. Sikov W. Safran H. King TC, Griffith RC: Fluorescent in situ hybridization for assessing the proportion of cells with trisomy 4 in a patient with acute non-lymphoblastic leukemia. Ann Clin Lab Sci 1995:25:330-335.
15. Mark HFL, Baylcran JK. Seifer DB, Meyers Seifer CH: A combined cytogenetic and molecular approach for diagnosing delayed puberty. Clin Pediatr (Phila) 1996:35:62-66.
16. Young C. DiBcnedetto J, Glasser L. Mark HFL: A Philadelphia chromosome positive CML patient with a unique translocation studied via GTG banding and fluorescent in situ hybridization. Cancer Genet Cytogenet 1996: 89:157-162.
17. Mark HFL: Fluorescent in situ hybridization as an adjunct to conventional cytogenetics. Ann Clin Lab Sci 1994:24:153-163.
18. Miranda RN. Mark HFL. Medeiros U: Fluorescent in situ hybridization in routinely processed bone marrow aspirate clot and core biopsy sections. Am J Pathol 1994:145:1-6.
19. Mark HFL. Grollino MG. Sulaiman RA. Lathrop JC: Fluorescent in situ hybridization (FISH) assessment of chromosome copy number in gestational trophoblastic disease. Ann Clin Lab Sci 1995;25:291-296.
20. Mark HFL, Meyers-Seifcr C. Seifer D. DeMo-ranville B. Jackson IM: Assessment of sex chromosome composition using FISH as an adjunct to GTG banding. Ann Clin Lab Sci 1995:25: 402-408.
21. Mark HFL, Sheu M. Lopes L, Campagnonc J. Takezawa K, Santoro K. Sigman M: Towards the development of a fluorescent in situ hybridization based genotoxicologic assay for aneu-ploidy detection in sperm. Cytobios 1995:82: 171-180.
22. Mark HFL. Chow B: Localization of the gene encoding the secretin receptor on human chromosome 2q by fluorescent in situ hybridization and chromosome morphometry. Genomics 1995;29:817-818.
23. Afifv A. Bland KL. Mark HFL: Fluorescent in situ hybridization assessment of chromosome 8 copy number in breast cancer. Breast Cancer Res Treat 1996:38:201-208.
24. Mark HFL. Santoro K. Campbell W. Lathrop J: Integration of human papillomavirus sequences in cervical tumor cell lines. Ann Clin Lab Sci 1996;26:147-153.
25. Mark HFL. Mills D. Kim E. Santoro K. Qud-dus M. Lathrop JC: Fluorescent in situ hybridization assessment of chromosome copy number in buccal mucosal cells. Cytobios 1997:87: 117-126.
26. Mark HFL, Mills D. Santoro K. Quddus M, Lathrop JC: Fluorescent in situ hybridization (FISH) analysis of cervical smears: A pilot study of 20 cases. Ann Clin Lab Sci 1997;27: 224-229.
27. Mark HFL, Afify A, Taylor W, Santoro K, Lathrop JC: A Subset of gestational trophoblastic disease (GTD) characterized by abnormal chromosome 8 copy number detected by FISH? Cancer Genet Cytogenet, in press.
28. Mark HFL. Huth A. Santoro K. Ferreira K. Barker B: Sequential flow cytometry and FISH for the study of formalin-fixed paraffin-embedded breast cancer tissues. Cancer Genet Cytogenet 1997;98:1-5.
29. Oscier D, Fitchett M, Herbert T, Lambert R: Karyotypic evolution in B-ccll chronic lymphocytic leukaemia. Genes Chromosomes Cancer 1991;3:16-20.
30. Riggs CE Jr: Antitumor Antibiotics and Related Compounds: in Perry MC (ed): The Chemotherapy Source Book. Philadelphia. Williams & Wilkins, 1996, p 345.
31. Sandoval C, Pui CH, Bowman LC. Heaton D, Hurwitz CA, Raimondi SC, Behm FG, Head DR: Secondary acute myeloid leukemia in children previously treated with alkylating agents, interclating topoisomerase II inhibitors and irradiation. J Clin Oncol 1993; 11:1039-1045.
32. Pcdcrscn-Bjergaard J, Sigsgaard TC, Nielsen D, Gjedde SB. Philip P, Hansen M. Larsen SO, Rorth M, Mouridsen H, Dombernowsky P: Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 1 lq23 after therapy with 4-epi-doxorubi-cin and cisplatin or cyclophosphamide for breast cancer. J Clin Oncol 1992:10:1444-1451.
33. Super HJG. McCabe NR. Thirman MJ. Larson RA. Lc Beau MM, Pedersen-Bjergaard J, Philip P. Diaz MO, Rowley JD: Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomcrasc II. Blood 1993;82:3705-3711.
34. Felix CA. Hosier MR. Winick MH, Masterson M, Wilson AE, Lange BJ: ALL-1 gene rearrangements in DNA topoisomerae II inhibitor-related leukemia in children. Blood 1995;85: 3250-3256.
35. Bseiso AW, Kantarjian J. Estey E: Case report: Myclodysplastic syndrome following successful therapy of acute promyelocytic leukemia. Leukemia 1997;11:168-173.
36. Jubashi T. Nagai K. Miyazaki Y. Nakamura H, Matsuo T, Kuriyama K, Tomonaga M: A unique case of t(15;17) acute promyelocytic leukaemia (M3) developing into acute myelo-blastic leukaemia (ml) with t(7;21) at relapse. Br J Haematol 1993;83:665-668.
37. Todisco E, Testi AM, Avvisati G, Moleti ML, Cedrone M, Cimino G, Mancini F, Amadori S, Mandelli F: Therapy related acute myelogenous leukemia following successful therapy for APL Leukemia 1995:9:1583-1585.
38. Heim S. Mitclman F: Cancer Cytogenetics, ed 2. New York, Wilcy-Liss, 1995.